Skip to main content
. Author manuscript; available in PMC: 2012 Jan 11.
Published in final edited form as: Toxicology. 2010 Oct 8;279(1-3):54–64. doi: 10.1016/j.tox.2010.09.007

Figure 1. Physiological changes in cardiomyocyte behavior caused by DEHP (50 μg/mL) treatment.

Figure 1

(A) Calcium transient measurements were recorded from 4 regions of interest on a cardiomyocyte monolayer using Fluo-4, a calcium indicator dye. DEHP treatment (50 μg/mL) results in marked uncoupling between the different regions of the cell network (right) compared with untreated control samples (left).